Edition:
United States

Insider Trading: Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.27USD
19 Jul 2019
Change (% chg)

$-0.17 (-4.94%)
Prev Close
$3.44
Open
$3.45
Day's High
$3.45
Day's Low
$3.24
Volume
51,579
Avg. Vol
72,636
52-wk High
$14.52
52-wk Low
$3.20

All Insider Trades
Trading Date Name Title Type Shares Traded Price
13 Jan 2019

Amado (Rafael M.D.)

Officer Sell 3,028 $5.37
13 Jan 2019

Binder-Scholl (Gwendolyn Knowlton Ph.D.)

Chief Technology Officer Sell 1,514 $5.37
13 Jan 2019

Bertrand William C Jr

Chief Operating Officer Sell 2,271 $5.37
13 Jan 2019

Rawcliffe Adrian

Chief Financial Officer Sell 3,084 $5.37
30 Sep 2018

Binder-Scholl (Gwendolyn Knowlton Ph.D.)

Chief Technology Officer Sell 25,000 $13.79
28 Aug 2018

Binder-Scholl (Gwendolyn Knowlton Ph.D.)

Chief Technology Officer Sell 25,000 $10.25
5 Jun 2018

Thompson (Peter A)

Director Sell 1,600 $13.49
5 Jun 2018

OrbiMed Advisors, L.L.C.

Unknown Sell 1,600 $13.49
3 Jun 2018

OrbiMed Advisors, L.L.C.

Unknown Sell 17,100 $13.57
3 Jun 2018

Thompson (Peter A)

Director Sell 17,100 $13.57
31 May 2018

Thompson (Peter A)

Director Sell 50,000 $13.49
31 May 2018

OrbiMed Advisors, L.L.C.

Unknown Sell 50,000 $13.49
29 May 2018

Thompson (Peter A)

Director Sell 121,000 $13.52
29 May 2018

OrbiMed Advisors, L.L.C.

Unknown Sell 121,000 $13.52
13 May 2018

Thompson (Peter A)

Director Sell 10,300 $13.50
13 May 2018

Orbimed Advisors Llc

Director Sell 10,300 $13.50
28 Mar 2018

Thompson (Peter A)

Director Sell 31,983 $11.53
28 Mar 2018

Orbimed Advisors Llc

Beneficial Owner of More than 10% Class Sell 31,983 $11.53
26 Mar 2018

New Enterprise Associates 14, L.P.

Beneficial Owner of More than 10% Class Buy 6,000,000 $1.92
26 Mar 2018

Barris (Peter J)

Beneficial Owner of More than 10% Class Buy 6,000,000 $1.92
26 Mar 2018

Florence (Anthony A JR)

Beneficial Owner of More than 10% Class Buy 6,000,000 $1.92
26 Mar 2018

Kerins Patrick J

Beneficial Owner of More than 10% Class Buy 6,000,000 $1.92
26 Mar 2018

Orbimed Advisors Llc

Beneficial Owner of More than 10% Class Sell 1,016,084 $11.50
26 Mar 2018

Sonsini Peter W

Beneficial Owner of More than 10% Class Buy 6,000,000 $1.92
26 Mar 2018

Barrett (Michael James Ph.D.)

Beneficial Owner of More than 10% Class Buy 6,000,000 $1.92

Institutional Holders

% Shares Owned: 73.44%
# of Holders: 77
Total Shares Held: 76,913,043
3 Mo. Net Change: 196,302
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

David Mott

53 2017 Non-Executive Chairman of the Board

James Noble

2014 Chief Executive Officer, Director

Adrian Rawcliffe

46 2015 Chief Financial Officer

William Bertrand

53 2017 Chief Operating Officer

Sebastien Desprez

2017 Vice President - Communications and Investor Relations

Paul Stead

2018 Vice President - Business Development

Rafael Amado

51 2015 Chief Medical Officer

Helen Tayton-Martin

49 2017 Chief Business Officer

Lawrence Alleva

68 2015 Non-Executive Independent Director

Ali Behbahani

41 2014 Non-Executive Independent Director

Barbara Duncan

54 2016 Independent Non-Executive Director

John Furey

53 2018 Non-Executive Independent Director

Giles Kerr

57 2016 Independent Non-Executive Director

Charles Sigal

66 2014 Non-Executive Independent Director

Tal Zaks

2016 Independent Non-Executive Director